Clinical Outcomes for Patients With Renal Cell Carcinoma Who Received First-Line Sunitinib

Clinical trial NCT04076787 · COMPLETED

Trial details

NCT number: NCT04076787
Sponsor: Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

Metastatic Renal Cell Carcinoma

Start date: 2018-09-01
Primary completion: 2018-09-02
Enrollment: 1769

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.